These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 19141649

  • 1. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.
    Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggiò S, Tetè S, Polishchuk R, Castronovo V, Buccione R.
    Cancer Res; 2009 Feb 01; 69(3):747-52. PubMed ID: 19141649
    [Abstract] [Full Text] [Related]

  • 2. FGD1 as a central regulator of extracellular matrix remodelling--lessons from faciogenital dysplasia.
    Genot E, Daubon T, Sorrentino V, Buccione R.
    J Cell Sci; 2012 Jul 15; 125(Pt 14):3265-70. PubMed ID: 22854039
    [Abstract] [Full Text] [Related]

  • 3. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K.
    Cancer Res; 2009 Nov 15; 69(22):8594-602. PubMed ID: 19887621
    [Abstract] [Full Text] [Related]

  • 4. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC.
    Cancer Res; 2006 Mar 15; 66(6):3034-43. PubMed ID: 16540652
    [Abstract] [Full Text] [Related]

  • 5. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.
    Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R.
    J Cell Sci; 2008 Feb 01; 121(Pt 3):369-78. PubMed ID: 18198194
    [Abstract] [Full Text] [Related]

  • 6. Skeletal-specific expression of Fgd1 during bone formation and skeletal defects in faciogenital dysplasia (FGDY; Aarskog syndrome).
    Gorski JL, Estrada L, Hu C, Liu Z.
    Dev Dyn; 2000 Aug 01; 218(4):573-86. PubMed ID: 10906777
    [Abstract] [Full Text] [Related]

  • 7. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA, Jia L, Eves R, Mak AS.
    Eur J Cell Biol; 2007 Apr 01; 86(4):189-206. PubMed ID: 17343955
    [Abstract] [Full Text] [Related]

  • 8. MT1-MMP-dependent invasion is regulated by TI-VAMP/VAMP7.
    Steffen A, Le Dez G, Poincloux R, Recchi C, Nassoy P, Rottner K, Galli T, Chavrier P.
    Curr Biol; 2008 Jun 24; 18(12):926-31. PubMed ID: 18571410
    [Abstract] [Full Text] [Related]

  • 9. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
    Rey M, Irondelle M, Waharte F, Lizarraga F, Chavrier P.
    Eur J Cell Biol; 2011 Jun 24; 90(2-3):128-35. PubMed ID: 20970878
    [Abstract] [Full Text] [Related]

  • 10. Formation of extracellular matrix-digesting invadopodia by primary aortic smooth muscle cells.
    Furmaniak-Kazmierczak E, Crawley SW, Carter RL, Maurice DH, Côté GP.
    Circ Res; 2007 May 11; 100(9):1328-36. PubMed ID: 17446433
    [Abstract] [Full Text] [Related]

  • 11. The Aarskog-Scott syndrome protein Fgd1 regulates podosome formation and extracellular matrix remodeling in transforming growth factor β-stimulated aortic endothelial cells.
    Daubon T, Buccione R, Génot E.
    Mol Cell Biol; 2011 Nov 11; 31(22):4430-41. PubMed ID: 21911474
    [Abstract] [Full Text] [Related]

  • 12. The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells.
    Gao L, Gorski JL, Chen CS.
    Am J Pathol; 2011 Mar 11; 178(3):969-74. PubMed ID: 21356349
    [Abstract] [Full Text] [Related]

  • 13. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
    Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC.
    Oncogene; 1999 Aug 05; 18(31):4440-9. PubMed ID: 10442635
    [Abstract] [Full Text] [Related]

  • 14. Intersection of TKS5 and FGD1/CDC42 signaling cascades directs the formation of invadopodia.
    Zagryazhskaya-Masson A, Monteiro P, Macé AS, Castagnino A, Ferrari R, Infante E, Duperray-Susini A, Dingli F, Lanyi A, Loew D, Génot E, Chavrier P.
    J Cell Biol; 2020 Sep 07; 219(9):. PubMed ID: 32673397
    [Abstract] [Full Text] [Related]

  • 15. Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1.
    Hayakawa M, Matsushima M, Hagiwara H, Oshima T, Fujino T, Ando K, Kikugawa K, Tanaka H, Miyazawa K, Kitagawa M.
    Genes Cells; 2008 Apr 07; 13(4):329-42. PubMed ID: 18363964
    [Abstract] [Full Text] [Related]

  • 16. Aiming for invadopodia: organizing polarized delivery at sites of invasion.
    Caldieri G, Buccione R.
    Trends Cell Biol; 2010 Feb 07; 20(2):64-70. PubMed ID: 19931459
    [Abstract] [Full Text] [Related]

  • 17. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
    Lizárraga F, Poincloux R, Romao M, Montagnac G, Le Dez G, Bonne I, Rigaill G, Raposo G, Chavrier P.
    Cancer Res; 2009 Apr 01; 69(7):2792-800. PubMed ID: 19276357
    [Abstract] [Full Text] [Related]

  • 18. Polarised apical-like intracellular sorting and trafficking regulates invadopodia formation and degradation of the extracellular matrix in cancer cells.
    Caldieri G, Capestrano M, Bicanova K, Beznoussenko G, Baldassarre M, Buccione R.
    Eur J Cell Biol; 2012 Apr 01; 91(11-12):961-8. PubMed ID: 22564726
    [Abstract] [Full Text] [Related]

  • 19. Invadopodia: at the cutting edge of tumour invasion.
    Stylli SS, Kaye AH, Lock P.
    J Clin Neurosci; 2008 Jul 01; 15(7):725-37. PubMed ID: 18468901
    [Abstract] [Full Text] [Related]

  • 20. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES, Whigham AS, Yarbrough WG, Weaver AM.
    Cancer Res; 2007 May 01; 67(9):4227-35. PubMed ID: 17483334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.